Heimbach James T
JHeimbach LLC, Port Royal, Virginia 22535, USA.
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S122-4; discussion S144-51. doi: 10.1086/523327.
Manufacturers wish to communicate the benefits of probiotics in advertising and labeling with lawful and adequately substantiated claims. Regulatory and substantiation requirements differ for products intended to cure, treat, prevent, or mitigate a disease; to reduce a healthy individual's risk of developing a disease; or to affect the structure or function of the body. Food labeling is regulated by the US Food and Drug Administration, and advertising is regulated by the Federal Trade Commission; the standards and methods used by these agencies differ. Food manufacturers must design their claims regarding the benefits of probiotics with the regulatory environment in mind and must develop their research plans to provide evidence that satisfies the agencies' substantiation requirements. This article offers an overview of the applicable laws and regulations, what they mandate regarding legitimate claims, and the issues regarding the design of research to substantiate such claims.
制造商希望在广告和标签中通过合法且有充分依据的声明来传达益生菌的益处。对于旨在治愈、治疗、预防或减轻疾病、降低健康个体患疾病风险或影响身体结构或功能的产品,监管和依据要求有所不同。食品标签由美国食品药品监督管理局监管,广告由联邦贸易委员会监管;这些机构使用的标准和方法各不相同。食品制造商在设计有关益生菌益处的声明时必须考虑监管环境,并且必须制定研究计划以提供满足各机构依据要求的证据。本文概述了适用的法律法规、它们对合法声明的规定以及证实此类声明的研究设计相关问题。